In patients with CKD, especially in advanced stages, procalcifying factors related to mineral bone disease (CKD-MBD), such as increased parathyroid hormone and serum phosphate, but also uremic toxins and inflammatory biomarkers, trigger and drive valvular calcification. The gene discussed is PTH; the disease is Marchiafava-Bignami disease.